ABOUT THE PRODUCT
A novel small molecule therapy for acute pancreatitis, currently undergoing Phase II clinical trials in partnership with Arrivo BioVentures. A promising treatment for canine acute pancreatitis is also being developed.
Information is owner-confirmed
Last updated 5 months ago
Price range
Other products/services from Lamassu BioTech
SA53
Biotechnology
N/A
Lamassu BioTech
United States (US)